Stockscreener 앱 받기
2.03
0.49%
-0.01
시간 외 거래:
2.01
-0.02
-0.99%
Heartsciences Inc 주식(HSCS)의 최신 뉴스
HeartSciences signs first SaaS revenues agreement following full launch of MyoVista Insights(TM) - marketscreener.com
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™ - The Manila Times
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights - Weekly Voice
Heartsciences Signs First Saas Revenues Agreement Following Full Launch Of Myovista Insights - TradingView
Colorado hospital becomes first paying MyoVista Insights customer - Stock Titan
HeartSciences (HSCS) Detailed Report | Q1 2026: EPS Tops ViewsDirect Listing - Cổng thông tin điện tử tỉnh Lào Cai
HSCS (HeartSciences Inc.) reports narrower Q1 2026 loss than analyst estimates even as yearly revenue falls sharply, lifting its shares modestly.Debt Refinancing - UBND thành phố Hải Phòng
HSCS (HeartSciences) shares drop 3.2 percent despite Q1 2026 EPS beat as revenue plummets year over year.Dividend Suspension - Cổng thông tin điện tử tỉnh Tây Ninh
HeartSciences (HSCS) Stock Prediction: What’s Next After Recent Move (Breakdown Watch) 2026-04-20 - Newser
HeartSciences (HSCS) Stock: Why Options Traders Watch It (Marginal Gain) 2026-04-15Insider Selling - Cổng thông tin điện tử Tỉnh Sơn La
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting - 富途牛牛
HeartSciences shareholders have until April 29 to vote online - Stock Titan
Growth Report: Does HeartSciences Inc offer margin of safety2026 Snapshot & Safe Entry Trade Reports - baoquankhu1.vn
Can HeartSciences (HSCS) Stock Reach New Highs | Price at $2.29, Up 0.66%Trending Stock Ideas - Newser
Is HeartSciences (HSCS) Stock Slowing Down | Price at $2.26, Down 1.74%Market Analysis - Newser
HeartSciences Announces Passing of COO Mark Hilz; No Changes to Product Plans or Leadership Structure - Minichart
HeartSciences reports passing of COO Mark Hilz, will not seek immediate replacement - Investing.com Australia
HeartSciences COO and Longtime Board Member Passes Away - TipRanks
HeartSc's COO Mark Hilz dies; served on board since 2013 - TradingView
HeartSciences (HSCS) announces death of COO and director, affirms business plans - Stock Titan
Aug Highlights: Is HeartSciences Inc in a long term uptrend2026 Selloffs & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Exit Recap: Can HeartSciences Inc Equity Warrant outperform under higher oil prices2026 Institutional & Reliable Price Breakout Alerts - baoquankhu1.vn
Aug Retail: Can HeartSciences Inc expand its profit margins2026 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn
Big Picture: Will HeartSciences Inc Equity Warrant benefit from geopolitical trendsGlobal Markets & Verified Momentum Stock Watchlist - baoquankhu1.vn
HSCSW SEC FilingsHeartSciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category - The Manila Times
APPlife Digital Solutions, Inc. Announces Weekly Investor Update Calls to Enhance Transparency and Shareholder Engagement - Weekly Voice
HeartSciences lands Epic Toolbox spot for ECG workflow software - Stock Titan
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings - The Manila Times
HeartSciences Inc. to Present at Investor Summit Group Virtual Conference on March 25, 2026 - Quiver Quantitative
HeartSciences CEO to outline strategy in virtual investor meetings - Stock Titan
Pfizer To Rally More Than 34%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
HSCS Receives Analyst Rating Update: Price Target Lowered by Asc - GuruFocus
Aug Update: What drives HeartSciences Inc Equity Warrants stock price2026 Outlook & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
If You Invested $1,000 in HeartSciences Inc (HSCS) - Stock Titan
Growth Report: Can HeartSciences Inc Equity Warrant ride the EV waveStop Loss & Real-Time Buy Signal Notifications - baoquankhu1.vn
HeartSciences (NASDAQ: HSCS) seeks approval for larger equity plan and officer shield - Stock Titan
Experience real-time quotes, in-depth charts, and analyst ratings - webull.com
HeartSciences Reports Q3 2026 Results, Provides Business Update - National Today
HeartSciences Inc. Reports Fiscal Third Quarter 2026 Financial Results and Progress on MyoVista Insights™ Platform - Quiver Quantitative
HeartSciences (NASDAQ: HSCS) posts fiscal Q3 2026 results and files FDA 510(k) - Stock Titan
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - The Globe and Mail
HeartSciences (NASDAQ: HSCS) posts Q3 loss and flags going concern risk - Stock Titan
HeartSciences 10-Q: Revenue $0.00M (Q) / $0.004M (9M); EPS $(0.63) Q, $(2.61) 9M - TradingView
ETF Watch: Can HeartSciences Inc expand its profit marginsDip Buying & Expert Approved Momentum Ideas - baoquankhu1.vn
MACD Signal: Can HeartSciences Inc expand its profit marginsQuarterly Profit Review & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Update Report: Can HeartSciences Inc expand its profit margins2026 Closing Moves & Daily Oversold Bounce Ideas - baoquankhu1.vn
Is HeartSciences Inc. stock undervalued vs historical averages2026 Macro Impact & Safe Swing Trade Setup Alerts - Naître et grandir
Bank Watch: Is SLM Corporation still a buy after recent gainsIndex Update & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Will SmartKem Inc. stock attract more institutional investorsJuly 2025 Intraday Action & Real-Time Volume Trigger Notifications - Naître et grandir
Is HeartSciences Inc. Equity Warrant stock a safe haven assetJuly 2025 Analyst Calls & Intraday High Probability Alerts - Naître et grandir
Update Recap: How does Oak Woods Acquisition Corporation Equity Right compare to its peersShare Buyback & High Accuracy Buy Signal Tips - baoquankhu1.vn
0.41%
0.93%
자본화:
|
볼륨(24시간):